NASDAQ:LGND   Ligand Pharmaceuticals Incorporated
3
Notes on chart. No edge into earnings - even a straddle is risky as it may not make "the move" on it's report.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。